ECSP067022A - Tratamiento de infecciones micóticas - Google Patents

Tratamiento de infecciones micóticas

Info

Publication number
ECSP067022A
ECSP067022A EC2006007022A ECSP067022A ECSP067022A EC SP067022 A ECSP067022 A EC SP067022A EC 2006007022 A EC2006007022 A EC 2006007022A EC SP067022 A ECSP067022 A EC SP067022A EC SP067022 A ECSP067022 A EC SP067022A
Authority
EC
Ecuador
Prior art keywords
micological
infections
treatment
antibody
composition
Prior art date
Application number
EC2006007022A
Other languages
English (en)
Inventor
James Peter Burnie
Ruth Christine Matthews
Original Assignee
Neutec Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Plc filed Critical Neutec Pharma Plc
Publication of ECSP067022A publication Critical patent/ECSP067022A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se expone una composición que comprende un anticuerpo o un fragmento de unión con antígenos del mismo específico para al menos un epítope de hsp90 proveniente de un organismo del género Aspergillus, y al menos un agente antimicótico seleccionado del grupo que consiste: itraconazol y voriconazol.
EC2006007022A 2004-04-23 2006-11-23 Tratamiento de infecciones micóticas ECSP067022A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0409077.5A GB0409077D0 (en) 2004-04-23 2004-04-23 Treatment of fungal infections

Publications (1)

Publication Number Publication Date
ECSP067022A true ECSP067022A (es) 2007-02-28

Family

ID=32344282

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006007022A ECSP067022A (es) 2004-04-23 2006-11-23 Tratamiento de infecciones micóticas

Country Status (30)

Country Link
US (1) US7785571B2 (es)
EP (3) EP2044954A1 (es)
JP (1) JP2007533716A (es)
KR (1) KR20080024944A (es)
CN (1) CN1946424A (es)
AT (1) ATE424846T1 (es)
AU (1) AU2005235339B2 (es)
BR (1) BRPI0510052A (es)
CA (1) CA2564137A1 (es)
CY (1) CY1109121T1 (es)
DE (1) DE602005013197D1 (es)
DK (1) DK1737488T3 (es)
EC (1) ECSP067022A (es)
ES (1) ES2322171T3 (es)
GB (1) GB0409077D0 (es)
HK (1) HK1100320A1 (es)
HR (1) HRP20090261T1 (es)
IL (1) IL178565A0 (es)
MA (1) MA28717B1 (es)
MX (1) MXPA06012256A (es)
NO (1) NO20065246L (es)
NZ (1) NZ550450A (es)
PL (1) PL1737488T3 (es)
PT (1) PT1737488E (es)
RU (1) RU2380116C2 (es)
SG (1) SG152269A1 (es)
SI (1) SI1737488T1 (es)
TN (1) TNSN06339A1 (es)
WO (1) WO2005102386A1 (es)
ZA (1) ZA200608767B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100113355A1 (en) * 2007-04-27 2010-05-06 Naresh Chennamsetty Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
WO2013024517A1 (ja) * 2011-08-12 2013-02-21 国立感染症研究所 アスペルギルス フミガーツス感染症の検査、予防及び治療のための方法並びに組成物
CN111116743B (zh) * 2018-10-30 2022-01-28 迈威(上海)生物科技股份有限公司 Hsp90抗体及其在抗真菌感染中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8915019D0 (en) 1989-06-30 1989-08-23 Matthews Ruth C Medicaments
US5952300A (en) * 1996-04-19 1999-09-14 Merck & Co., Inc. Antifungal compositions
GB0008305D0 (en) * 2000-04-06 2000-05-24 Neutec Pharma Plc Treatment of fungal infections
BR0314763A (pt) * 2002-09-23 2005-07-26 Schering Corp Tratamento de infecções fúngicas

Also Published As

Publication number Publication date
IL178565A0 (en) 2007-02-11
RU2006141354A (ru) 2008-05-27
HRP20090261T1 (en) 2009-07-31
AU2005235339B2 (en) 2010-11-25
CY1109121T1 (el) 2014-07-02
DK1737488T3 (da) 2009-07-06
PL1737488T3 (pl) 2009-08-31
SG152269A1 (en) 2009-05-29
CA2564137A1 (en) 2005-11-03
TNSN06339A1 (en) 2008-02-22
NO20065246L (no) 2006-11-15
KR20080024944A (ko) 2008-03-19
EP2039369A1 (en) 2009-03-25
ES2322171T3 (es) 2009-06-17
EP1737488B1 (en) 2009-03-11
EP1737488A1 (en) 2007-01-03
CN1946424A (zh) 2007-04-11
ZA200608767B (en) 2008-06-25
DE602005013197D1 (de) 2009-04-23
AU2005235339A1 (en) 2005-11-03
RU2380116C2 (ru) 2010-01-27
NZ550450A (en) 2009-02-28
BRPI0510052A (pt) 2007-10-16
EP2044954A1 (en) 2009-04-08
PT1737488E (pt) 2009-05-11
MXPA06012256A (es) 2007-06-15
SI1737488T1 (sl) 2009-08-31
US20080095778A1 (en) 2008-04-24
JP2007533716A (ja) 2007-11-22
GB0409077D0 (en) 2004-05-26
HK1100320A1 (en) 2007-09-14
MA28717B1 (fr) 2007-07-02
US7785571B2 (en) 2010-08-31
WO2005102386A1 (en) 2005-11-03
ATE424846T1 (de) 2009-03-15

Similar Documents

Publication Publication Date Title
CY1113224T1 (el) Νεο αντισωμα αντι-ρlgf
EP1797893A3 (en) Phosphorylcholine conjugates and corresponding antibodies
CY1110783T1 (el) Μονοκλωνικα αντισωματα κατα αυξητικου παραγοντα ηπατοκυτταρων
CY1112277T1 (el) ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ΑΝΤΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
CY1111622T1 (el) Ανθρωποποιημενοι ανταγωνιστες anti-cmet
DK1718677T3 (da) Monovalente antistoffragmenter egnede som terapeutiske midler
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
WO2007075525A3 (en) Combination of an iap-inhibitor and a taxane7
WO2005010048A3 (en) Rg1 antibodies and uses thereof
DE60138867D1 (de) Medikament zum Schutz gegen thrombotische Krankheiten
WO2005067956A3 (en) Use of interleukin-21 for the treatment of autoimune diseases and allograft rejection
GB0008305D0 (en) Treatment of fungal infections
WO2006137938A3 (en) Antibody fragments for protection from pathogen infection and methods of use thereof
WO2002057794A3 (en) Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies
DK1411962T3 (da) Terapi for pancreacancer med monoklonalt stof
ECSP067022A (es) Tratamiento de infecciones micóticas
AR055072A1 (es) Uso de anticuerpos anti- madcam para el tratamiento de enfermedad celiaca y esprue tropical
WO2005047309A3 (en) Prophylactic and therapeutic monoclonal antibodies
CY1116949T1 (el) M-csf-ειδικο μονοκλωνικο αντισωμα και χρησεις αυτου